694,09 €

10th World Congress on Medicinal Chemistry and Drug Design

Informations sur l'événement

Partager cet événement

Date et heure



Conference Series llc LTD, 47 Churchfield Road, London, W3 6AY, UK

Politique de remboursement

Politique de remboursement

Remboursements jusqu'à 30 jours avant l'événement

Description de l'événement


Pharmaceutical Chemistry, Comprehensive Chemistry, Bioorganic and Medicinal Chemistry , Recent Trends in Drug Design and Drug Development , Computational Chemistry, Pharmacology , Organic Chemistry, Analytical Chemistry , Chemical Biology, Anticancer Agents in Medicinal Chemistry , Bioorganometallic Chemistry and Toxicology, Biopharmaceuticals and Radiopharmaceuticals, Pharmaceutical Industry Trends, Pharmacotoxicology . Conference Series Conferences has taken the first step in bringing together the world class experts from a common platform.

Medicinal Chemistry focuses on all aspects concerned with the substances of which matter is composed, the investigation of their properties and reactions, and the use of such reactions to form new substances.

Target audience: Chairperson, Director / Dean, Associate Professors, PhD students and post graduates of Chemistry, Pharmaceuticals , Biology and Physical Sciences, Chemical Biology , Analytical Chemistry, Nano Science , and related fields.

The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post) doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry & Pharmacology , Drug Discovery Software, Future Med Chem and Scientists of Relevant Field.

For abstract submission please: http://medicinalchemistry.pharmaceuticalconferences.com/europe/abstract-submission.php

Email: medicinalchemistry@chemistryconference.org

ConferenceSeries organized 800+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishers 400+ Open access journals which contains over 50000 eminent personalities, reputed scientists and editorial board members.

Market Analysis

Chemistry is the branch of science concerned with the substance of the substance of the invention, the investigation of their properties and reactions, and the use of such reactions to form new substances.

Medicinal Chemistry 2018 offers the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, the practical challenges encountered and the solutions adopted in the fields.

The mission of the Medicinal Chemistry 2018 is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical / structural chemistry. This idea is intended to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemistry's ability to translate into new molecular concepts and to new molecular entities. pharmacology, molecular biology, systems biology.

For these reasons, the School is directed to participants at a graduate and post-graduate level, in chemistry and biology, who are keen to explore the interdisciplinary context of current cutting-edge research in medicinal chemistry.

To achieve these very ambitious goals, the conference series is organized into thematic sessions.

Conference Highlights:

Medicinal Chemistry

Pharmaceutical Sciences

Drug Design and Drug Development

CADD (Computer Aided Drug Design)

Bioorganic and Medicinal Chemistry

Pharmacology and toxicology

Anticancer agents in Medicinal Chemistry

Analytical Chemistry

Pharmaceutical Industry

Organic Chemistry

Why to wait ???

With Chemistry, Chemistry, Pharmaceutical Chemistry, Organic and Inorganic Chemistry; This is your best opportunity to reach the largest assembly of participants. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive your name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the latest updates in this hallmark of this conference.

Target audience:

Directors, Presidents & CEO's of companies, Pharmaceutical Chemistry, Chemistry, Chemical Biology, Pharmacology, Analytical and Bioanalytical Sciences. Delegates from various Pharma & Instrumental companies from all over the world.

Market Analysis:

Medicinal Chemistry for Drug Discovery Market: Overview

Over the last decade, industry's productivity has been declining with rising R & D costs. Medicinal chemistry is a well-known clinical approach to identification, synthesis and drug development for therapeutic applications. This science has evolved from medical chemistry-focused processes in the field of high-throughput screening (HTS) that are created by combinatorial chemistry based on few structural distinctions across large drug like scaffolds.

This change was needed because of high attrition rates in pre-clinical and incubation drug development studies because of earlier methods. While the primary task of medicinal chemists has not changed significantly over a period of time, the computational tools and chemicals have been extensively.

The various tools of medicinal chemistry are in silico modeling, structure-based drug design (SBDD), comparative molecular field analysis (CoMFA) or 3D QSAR method. In particular the fragment-based drug design promisingly stands out because of substantial improvements in research and productivity. One of the primary challenges of drug discovery is a robust drug that is both safe and effective in a wide range of populations. The various drug designing types are structure-based drug design, natural products-based drug design, fragment-based drug design, diversity-oriented synthesis and chemo genomics.

Medicinal Chemistry for Drug Discovery Market: Trends

To to to to to comb to comb to comb to comb AD comb AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADME and drug-like properties. The compound has to be synthesized and to minimize the attrition rate in preclinical testing, and must also include adsorption, distribution, metabolism, elimination and toxicity (ADMET).

During this process the ADMET has been established in vitro, in vitro and in vivo studies are often compiled into computational packages to enable chemists to predict the drug-likeliness of a compound.

The recent market trends are most likely to be influenced by cost-effectiveness and cost-effectiveness. India, China and Others from Asia Continent.

It has been estimated that $ 79 million in research funding has been paid since 2008. A complete overview of drug designing process has come up with some crucial details that from year 2008 to 2013 the market has a growth with $ 198 Billion and in more than $ 236 Billion from year 2014 to 2019. Special emphasis is made on computational approaches for drug discovery along with features and applications of the software used in de novo drug designing.

In the future year of 2020, the drug production is revealing that the large drug companies are facing the challenge of their best sellers. At the same time they are having trouble inventing new medicines, and this means that the drug industry may be at a disadvantage. The point of market analysis is to see what happens

Medicinal Chemistry for Drug Discovery Market: Opportunities and Competitive Dynamics

The mightiest challenge in this industry is to reduce the number of drugs that fail in pre-clinical stages, as this facilitates the manufacturer to enter the market with a high priced drug. But since the ADME profiling used in silico and cellular approaches have successfully reduced the attrition rate. According to industry experts currently structure-based drug design has high acceptance followed by fragment-based variation, natural products, while diversity oriented synthesis and chemo genomics have negligible market shares. The top five active therapeutic research areas are cancer, infections, neurological, gastrointestinal, endocrine and cardiovascular.

Drug discovery is expected to be widely practiced at small niche biopharmaceutical companies around the world in the UK, US, Western Europe, Eastern Europe, China, India, Brazil, South Africa and Mexico as investments, time and risks are comparatively less in this operations model than the traditional. Overall the medicinal chemistry has been improved with these technologies.

The importance of small and medium scaled companies will increase in this market as well as the cost of a large pharmaceutical company. Hence, in drug discovery medicinal chemistry plays important role in the accuracy and accuracy of the study.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections have been derived from the research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

• Market segments and sub-segments

• Market trends and dynamics

• Supply and demand

• Market size

• Current trends / opportunities / challenges

• Competitive landscape

• Technological breakthroughs

• Value chain and stakeholder analysis

The regional analysis covers:

• North America (US and Canada)

• Latin America (Mexico, Brazil, Peru, Chile, and others)

• Western Europe (Germany, UK, France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)

• Eastern Europe (Poland, Russia)

• Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)

• Middle East and Africa (GCC, Southern Africa, North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete set of qualitative and quantitative assessments by analysts and market participants across key points in the industry's value chain.

A separate analysis of prevailing trends in the parent market, macro-and micro-economic indicators, and regulations and mandates is included in the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Major Associations in Europe:

American Association of Pharmaceutical Scientists.

Association of the British Pharmaceutical Industry

American Board of Toxicology

Association of Biomolecular Resource Facilities

American Society for Clinical Pharmacology and Therapeutics

Genomics and bioinformatics resources and discussions

European Generic Medicines Association

European Federation for Pharmaceutical Sciences

International Pharmaceutical Federation

The Society for Life Science Professionals.

International Union of Pharmacology

Czech Chemical Society

Italian Chemical Society

American Association for Clinical Chemistry

American Chemical Society

American Institute of Chemists

Royal Society of Chemistry

Swedish Chemical Society

New Swiss Chemical Society

Spanish Society of Analytical Chemistry

Spanish Royal Society of Chemist

Past Conference Report

Medicinal Chemistry 2017

Medicinal Chemistry 2017

Conferenceseries successfully organized 6th World Congress on Medicinal Chemistry and Drug Design during June 07-08, 2017 at Milan, Italy and received great and fruitful response. Eminent Scientists, Researchers, Pharmacists, Industry Professionals and Scholars have made their resplendent presence and addressed the gathering.

The theme of the conference "Achieving Future Generation Advancements in Medicinal Chemistry and Drug Design"

Medicinal Chemistry 2017 Organizing Committee would like to thank the Moderator of the conference, Mr. John Turman, Biogen, USA, who contributed to this event.

Partager avec les amis

Date et heure


Conference Series llc LTD, 47 Churchfield Road, London, W3 6AY, UK

Politique de remboursement

Remboursements jusqu'à 30 jours avant l'événement

Sauvegarder cet événement

Événement sauvegardé